Navigation Links
Khosla Ventures and BIOeCON Form KiOR Inc.
Date:11/1/2007

Technology Development for the Conversion of Biomass to Bio-oil

MENLO PARK, California and HOEVELAKEN, The Netherlands, November 1 /PRNewswire/ -- Khosla Ventures and BIOeCON announce today the formation of their joint venture KiOR Inc. Khosla Ventures, will provide the Series A funding, whereas BIOeCON will bring its knowledge and intellectual property for the 'Biomass Catalytic Cracking Process' (BCC). KiOR Inc. will focus on the further development and commercialization of the BCC technology as well as prepare for raising significantly more capital in the next two to three years.

BCC technology converts lignocellulosic biomass, found in grass, wood, and various agricultural and forestry wastes, into a bio-oil product that can be further upgraded to transportation fuels. The conversion of cellulosic biomass to bio-oil represents a significant commercial opportunity that also offers important benefits, including using post-harvesting waste rather than competing with food crops; promoting environmental sustainability; reducing reliance on fossil fuels such as crude oil; and enabling economic development and job creation in rural areas.

"The key technical problem in the conversion of cellulosic biomass into usable fuels is how to open up the inaccessible solid fibrous 'woody' material, so that it can be effectively transformed. Most of the existing processes to unlock the woody structures are quite costly and intensive of energy or chemicals," says Paul O'Connor, founder and president of BIOeCON. "BIOeCON has developed a simple non-energy intensive way to make the woody biomass accessible to catalysts and convert to a bio-oil product with significantly improved product properties compared to other thermal-chemical processes.

Doug Cameron, Khosla Ventures' Chief Scientific Advisor: "BIOeCON has a strong R&D network and solid scientific fundamentals. We have done a thorough evaluation of the technology and research programs and believe
'/>"/>

SOURCE BIOeCON
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Tech companies get commerce loans for new ventures
2. Conference will focus on financing of early-stage ventures
3. Badger Ventures plans to fund IT; partisan stem-cell battle; BadgerNet draws fire
4. New Madison VC firm Badger Ventures looks for next big IT entrepreneurs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/20/2013)... Dental decay is the number one chronic disease ... Crisafulli of Crisafulli Dental those statistics are no longer daunting. ... and implemented a cavity prevention program developed by CariFree that ... to 74% . The system is known as ... a solution to dental decay that works,” says Dr. Crisafulli, ...
(Date:6/19/2013)... , June 20, 2013 ... productivity with technology solutions for pharmaceutical and chemical ... Glaxo Wellcome Manufacturing Pte. Ltd. and Siemens Pte. ... a new A*STAR R&D Consortium Programme - Innovative ... A*STAR,s Institute of Chemical and Engineering Sciences (ICES), ...
(Date:6/19/2013)... 19, 2013 An article posted earlier this ... increasing number of uses for probiotics. The article stated that ... the associate benefits may beeb listed, the actual use ... helping clear skin conditions. While the total uses of probiotics ... the the uses of these “miracle” bacterium, and debunked the ...
(Date:6/19/2013)... Clinverse, Inc. , a ... trials, today announced it will be exhibiting and ... in Boston, June 24-26, 2013. Clinverse’s eClinical ... fully configurable, cloud-based clinical financial lifecycle system. , ... Clinverse’s eClinical Commerce Network, automates site contract set-up ...
Breaking Biology Technology:Crisafulli Dental Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74% 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4Natural Acne Remedy, Probiotic Action Explains the Science behind Using Probiotics for Better Health 2Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2
... Stem cell-enriched autologous fat enables sustainable breast augmentation ... the media: For years a French company has been ... cause cancer. More than 100,000 women worldwide must now ... or carrying a "time bomb" in their bodies. Stem ...
... Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it will ... the Windsor Room of the Sir Francis Drake Hotel as ... emerging biotech companies held over 3 days this week in ... attendees are expected to be listening to presentations by up ...
... SEATTLE, Jan. 10, 2012  Omeros Corporation (NASDAQ: OMER ... selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, ... unlocked by Omeros to 23, representing 30 percent of the ... unlocked by Omeros for drug development equals half of the ...
Cached Biology Technology:Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 2Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 4Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 5
(Date:6/19/2013)... the journal Polar Biology, researchers report using DNA from tissues ... new type of killer whale ( Orcinus orca ). ... stranded on a New Zealand beach and a skeleton was ... but it was almost 50 years before this unique form ... and bulbous forehead, was documented alive in the wild. ...
(Date:6/19/2013)... Minn. , June 19, 2013 ... specializing in clinical study management systems, is pleased to ... to be held June 23-27 in Boston ... that MedNet, a recognized leader in cloud-based eClinical solutions, ... MedNet will be showcasing iMedNet™ EDC ...
(Date:6/19/2013)... A new variety of canary seeds bred specifically for ... be ideal for people with celiac disease (CD), scientists ... Journal of Agricultural and Food Chemistry . , ... least 3 million people in the United States alone ... eating wheat, barley, rye and other grains that contain ...
Breaking Biology News(10 mins):MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2
... Calling the results "extremely surprising," researchers from the ... report that methane gas concentrations in the Gulf of ... after a massive release occurred following the Deepwater Horizon ... led by oceanographers John Kessler of Texas A&M and ...
... exploring the genetic culprits behind a host of neuromuscular ... a team working at the National Institute of Standards ... single cells to extract and examine their mitochondria. ... "engines"the mitochondria that are in large part responsible for ...
... Jan. 6, 2011 News media now can apply for ... National Meeting & Exposition March 27-31, 2011, in Anaheim, Calif., ... Held during the International Year of Chemistry (IYC), ... Center and at area hotels. With nearly 9,500 presentations ...
Cached Biology News:UCSB, Texas A&M scientists find methane gas concentrations have returned to near-normal levels 2Extracting cellular 'engines' may aid in understanding mitochondrial diseases 2
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Full length YebU (Escherichia coli)...
Human Cell Line Slides...
Human Cell Line Slides...
Biology Products: